FDA Approved: ILEVRO — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for ILEVRO (nepafenac) submitted by Novartis Pharmaceuticals Corporation. This approval adds expanded labeling to cover …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Inflammation Following Cataract Surgery
• Postoperative Pain Following Cataract Surgery

Drugs mentioned

• ILEVRO (nepafenac)

Snippet

SUPPL AP for ILEVRO (NEPAFENAC)